Skip to content

Cancer Matters

 


prostate cancer

Cancer News Review: Top Stories

  • by
  • Uncategorized

Three stories top the list of major developments in cancer research during the past month.  Listen to these topics discussed in the most recent Cancer News Review podcast.

First, to treat or not to treat is the question for low-risk prostate cancer.  Whether to give aggressive treatments for low-risk cancer contained within the prostate is a controversy that many experts in the field still debate. Prostate cancer expert and Kimmel Cancer Center director William Nelson reviews a study analyzing how treatment decisions for these cancers are made and how quality of life expectations are communicated.  He says the current problem is that screening, which has helped decrease mortality from prostate cancer, has identified some men who could live their entire lives with prostate cancer but die of other causes.  He believes there are certain groups of men who should consider active surveillance programs to carefully monitor low-risk, organ-confined prostate cancer.

Read More »Cancer News Review: Top Stories